Pseudoginsenoside F11
Cat. No.：YN373128
| 产品名称: | Pseudoginsenoside F11 |
| CAS No.: | 69884-00-0 |
| Chemical Name: | (3β,6α,12β,24R)-20,24-epoxy-3,12,25-trihydroxydammaran-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside |
| Synonyms: | 拟人参皂苷 F11; Ginsenoside A1 |
| 分子量: | 801.01 |
| 分子式: | C₄₂H₇₂O₁₄ |
| SMILES: | C[C@@]([C@@]12C)(C[C@H](O[C@@](O[C@H](CO)[C@@H](O)[C@@H]3O)([H])[C@@H]3O[C@@](O[C@@H](C)[C@H](O)[C@H]4O)([H])[C@@H]4O)[C@@]5([H])C6(C)C)[C@@](C[C@@H](O)[C@]1([H])[C@]([C@]7(O[C@@H](C(C)(O)C)CC7)C)([H])CC2)([H])[C@]5(CC[C@@H]6O)C |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Pseudoginsenoside F11 (Ginsenoside A1) 是西洋参的组成成分，能够抵抗小鼠由莨菪碱、吗啡、脱氧麻黄碱诱导的学习记忆能力缺失。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Wang, H., Kong, L., Zhang, J., et al.The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivoSci. Rep.4,4986(2014)
Liu, Y.Y., Zhang, T.Y., Xue, X., et al.Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defectsCNS Neurosci. Ther.23(7),567-579(2017)
Li, Z., Wu, C.F., Pei, G., et al.Antagonistic effect of pseudoginsenoside-F11 on the behavioral actions of morphine in micePharmacol. Biochem. Behav.66(3),595-601(2000)
Zhang, Z., Yang, H., Yang, J., et al.Pseudoginsenoside-F11 attenuates cognitive impairment by ameliorating oxidative stress and neuroinflammation in ᴅ‑galactose-treated miceInt. Immunopharmacol.67,78-86(2019)
